Godrej Agrovet sales rise 10% in Q1 FY27; appoints Ravishankar A. as CFO
Godrej Agrovet Limited achieved 10% sales growth in Q1 FY27, reaching ₹2,852 crore, despite a decline in net profit to ₹128.31 crore. Strong performance in Animal Nutrition and Oil Palm offset challenges in Crop Care due to monsoon delays. The Board approved the appointment of Ravishankar A. as CFO, effective October 1, 2026.

*this image is generated using AI for illustrative purposes only.
Godrej Agrovet Limited reported a 10% year-on-year increase in consolidated sales to ₹2,852 crore for the first quarter ended June 30, 2026, driven by strong performance in Animal Nutrition and Oil Palm segments. Despite the top-line growth, net profit declined to ₹128.31 crore from ₹148.83 crore in Q1 FY26, reflecting margin pressures from elevated input costs and delayed monsoons impacting Crop Care volumes. The Board of Directors, meeting on August 5, 2026, approved the unaudited financial results and announced the appointment of Ravishankar A. as Chief Financial Officer, effective October 1, 2026, following the early superannuation of S. Varadaraj.
The earnings call held on August 6, 2026, provided deeper insights into segment performance and strategic outlooks. Managing Director Sunil Kataria highlighted that Animal Nutrition revenue grew 12.6% to ₹1,302.09 crore, supported by a 15% rise in cattle feed volumes and improved realizations. The Oil Palm business saw segment revenue surge 28.9%, aided by higher crude palm oil (CPO) realizations and improved oil extraction efficiency (OER), which rose to 18.8% from 18.4% in the previous year. Conversely, Crop Care revenue fell 16.2% due to a 40% deficit in June rainfall, delaying kharif sowing and reducing demand for cotton herbicides.
Segment-Wise Performance
| Segment: | Revenue (₹ crore): | YoY Change: | Key Drivers: |
|---|---|---|---|
| Animal Nutrition: | 1,302.09 | +12.6% | Cattle feed volume growth (+15%), premiumization |
| Vegetable Oil: | 619.24 | +24.1% | Higher CPO/PKO realizations, improved OER |
| Crop Care: | 349.02 | -13.3% | Delayed monsoon, lower cotton herbicide volumes |
| Dairy: | 464.63 | +11.5% | Value-added product growth, volume recovery |
| Poultry & Processed Food: | 188.17 | +0.7% | Branded portfolio expansion, live bird degrowth |
Astec LifeSciences continued its operational recovery, achieving EBITDA breakeven compared to an EBITDA loss of ₹11 crore in Q1 FY26. The company also noted that its Bangladesh joint venture, ACI Godrej Agrovet, returned to double-digit growth in volumes and profit before tax.
Strategic Outlook and Leadership Transition
S. Varadaraj requested early superannuation from his role as CFO and Head – Finance & Legal, effective September 30, 2026. The Board appointed Ravishankar A., formerly Vice President – Finance at Hindustan Unilever, as CFO-designate from September 21, 2026, with full appointment commencing October 1, 2026. This transition marks a significant shift in the company’s finance leadership.
Looking ahead, management maintained its guidance for mid-teens profit before tax growth for FY27, though it emphasized that final outcomes depend on Crop Care recovery in the second half. New product launches, including Ashitaka (maize herbicide) and Takai (paddy insecticide), are expected to contribute 18–20% of Q1 sales in their first season, diversifying the Crop Care portfolio beyond cotton herbicides. In the Oil Palm segment, the company plans to expand area coverage from 80,000 to 150,000 hectares over the long range, targeting high single-digit to early double-digit fresh fruit bunch (FFB) volume growth annually.
What the Numbers Show
The divergence between robust revenue growth (10%) and declining net profit (13.8%) highlights persistent margin compression across key segments. While Animal Nutrition and Oil Palm delivered strong top-line momentum, profitability was eroded by input cost inflation—particularly in milk procurement for Dairy and packaging costs linked to geopolitical tensions. The strategic pivot in Foods towards branded B2C products (growing at 28% volume) versus planned degrowth in live bird trading signals a structural shift towards higher-margin consumer offerings, albeit with short-term investment pressures.
Historical Stock Returns for Godrej Agrovet
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.42% | +2.56% | +21.54% | +12.21% | -8.74% | 0.0% |
How will the new CFO, Ravishankar A., leverage his FMCG background to address the current margin compression and optimize the shift towards higher-margin B2C branded products?
Given the 40% rainfall deficit impacting Crop Care, what specific hedging strategies or inventory management tactics will Godrej Agrovet employ to mitigate further revenue volatility in Q2 FY27?
What is the projected capital expenditure timeline for expanding the Oil Palm area from 80,000 to 150,000 hectares, and how might this impact free cash flow in the near term?


































